Table 3.
Adverse effects of treatment
| NICIC CTG grade | Grade 1,2 | Grade 3,4 |
|---|---|---|
| During induction chemotherapy (n = 58) | ||
| anemia | 5 (13.79%) | 1 (1.72%) |
| neutropenia | 5 (13.79%) | 15 (25.86%) |
| thrombocytopenia | 0 | 0 |
| alopecia | 0 | 58 (100%) |
| Weight loss | 3 (5.17%) | 0 |
| Hand foot syndrome | 28 (48.27%) | 0 |
| Mucositis/stomatitis | 33 (56.89%) | 1 (1.72%) |
| Febrile neutropenia | 0 | 6 (10.34%) |
| Acute kidney injury | 17 (29.31%) | 0 |
| Hyponatremia | 19 (32.75%) | 18 (31.03%) |
| Hypokalemia | 20 (34.48%) | 5 (13.79%) |
| nausea | 12 (20.68%) | 0 |
| vomiting | 1 (1.72%) | 0 |
| Diarrhea | 10 (17.24%) | 1 (1.72%) |
| Hearing loss | 10 (17.24%) | 0 |
| Lethargy | 4 (6.89%) | 1 (1.72%) |
| Peripheral neuropathy | 29 (50.00%) | 0 |